Combined concomitant boost radiotherapy and chemotherapy in stage III- IV head and neck carcinomas: A comparison of toxicity and treatment results with those observed after radiotherapy alone

Annals of Oncology

Volumn 8, Issue 7, 1997, Pages 681-684

  Allal, A S ^a   Bieri, S ^a   Miralbell, R ^a   Dulguerov, P ^a   Bardina, A ^a   Lehmann, W ^a   Kurtz, J M ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Accelerated radiotherapy; Chemotherapy; Head and neck cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030817189     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008260720076     Document Type: Article

References (29)

1. Horiot JC, Le Fur R, N'Guyen T et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231-41.
2. Sanchiz F, Milla A, Torner J et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1347-50.
3. Merlano M, Vitale V, Rosso R et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115-21.
4. Wang CC, Blitzer PH, Suit H. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985; 55: 2100-4.
5. Van den Bogaert W, Van der Schueren E, Horiot JC et al. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1986; 12: 587-91.
6. Horiot JC, Bontemps P, Begg AC et al. Hyperfractionated and accelerated radiotherapy in head and neck cancers: Facts from trials, impact on standard practice. Eur J Cancer 1995; 31A (Suppl 5): S69.
7. Hong WK, Bromer R. Current concepts: Chemotherapy in head and neck cancer. N Engl J Med 1983; 308: 75-9.
8. Vokes EE, Weichselbaum RR, Lippman SM, Ki Hong W. Head and neck cancer. N Engl J Med 1993; 328: 184-94.
9. Ang KK, Peters LJ, Weber RS et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990; 19: 1339-45.
10. Wang CC. Carcinoma of the oropharynx. In Wang CC (eds): Radiation Therapy for Head and Neck Neoplasms. Chicago: Year Book Medical Publishers, 1990; 186-206.
11. Stell PM, Rawson NSB. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990; 61: 779-87.
12. Taylor SG, Murthy AK, Caldarelli DD et al. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 1989; 7: 846-56.
13. Browman GP, Cripps C, Hodson DI et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994; 12: 2648-53.
14. Gupta NK, Pointon RC, Wilkinson PM. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin Radiol 1987; 38: 575-81.
15. Fu KK, Phillips TL, Silverberg IJ et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987; 5: 1410-8.
16. Lo TCM, Wiley AL, Ansfield FJ et al. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and orpharaynx: A randomized study. Am J Roentgenol Radium Ther Nucl Med 1976; 126: 229-35.
17. Adelstein DJ, Saxton JP, Lavertu P et al. Concurrent radiation and chemotherapy versus radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. J Clin Oncol 1996; 15: 26 (Abstr).
18. Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1985; 4: 1-7.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
20. Perez CA, Brady LW. Overview. In Perez CA, Brady LW (eds): Principales and Practice of Radiation Oncology. Philadelphia: Lippincott, 1992; 51-5.
21. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treament. Cancer 1981; 47: 207-14.
22. Saunders MI, Disch S, Grosch, EJ et al. Experience with CHART. Int J Radiat Oncol Biol Phys 1991; 21: 871-8.
23. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131-46.
24. Kummermehr J, Schropp K, Neuner M. Repopulation in squamous cell carcinoma AT 478 during daily irradiation. Experimentelle Tumor-therapie, Annual Report 1985, Munich, GSF-Bericht 31/85, 1986; 31-6.
25. Jacobs C. Adjuvant and neoadjuvant treatment of head and neck cancers. Semin Oncol 1991; 18: 504-14.
26. Overgaard J, Khan AR. Selective enhancement of radiation response in C3H mammary carcinoma by cisplatin. Cancer Treat Rep 1981; 65: 501-3.
27. Douple EB. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammine platinum (II). Int J Radiat Oncol Biol Phys 1979; 5: 1369-72.
28. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83-91.
29. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 838-47.